Nektar Therapeutics Reports Financial Results for the First Quarter of 2018

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Nektar Therapeutics Reports Financial Results for the First Quarter of 2018

Nektar Therapeutics (NKTR) Misses Q1 EPS by 69c, Miss on Revenues

May 10, 2018 4:20 PM EDT

Nektar Therapeutics (NASDAQ: NKTR) reported Q1 EPS of ($0.60), $0.69 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $38.02 million versus the consensus estimate of $140.61 million.

For earnings history and earnings-related data on Nektar Therapeutics (NKTR) click here.

... More